Effect of black tea intake on blood cholesterol concentrations in individuals with mild hypercholesterolemia: A diet-controlled randomized trial

Journal of the Academy of Nutrition and Dietetics

Volumn 115, Issue 2, 2015, Pages 264-271.e2

  Troup, Rasa ^a,b,c   Hayes, Jennifer H ^c,d   Raatz, Susan K ^a,e   Thyagarajan, Bharat ^c,f   Khaliq, Waseem ^f,g   Jacobs, David R ^f   Key, Nigel S ^a,h   Morawski, Bozena M ^f,i   Kaiser, Daniel ^j,k   Bank, Alan J ^c,k,l   Gross, Myron ^c,m  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Viverant   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

^g JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁱ University School of Medicine   (United States)

^j Yaso Therapeutics   (United States)

^k St Paul Heart Clinic   (United States)

^l United Heart and Vascular Clinic   (United States)

^m Molecular Epidemiology and Biomarker Research Laboratory   (United States)

more..

Author keywords

Black tea; Flavonoids; Hypercholesterolemia; Randomized crossover controlled trial; Serum lipids

Indexed keywords

CAMELLIA SINENSIS;

FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TEA; TRIACYLGLYCEROL;

AGED; BLOOD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TEA;

AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FEMALE; FLAVONOIDS; HUMANS; HYPERCHOLESTEROLEMIA; LINEAR MODELS; MALE; MIDDLE AGED; TEA; TRIGLYCERIDES;

EID: 84921825235     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2014.07.021     Document Type: Article

References (59)

1. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992, 21(3):334-350.
2. Hodgson J.M., Croft K.D. Tea flavonoids and cardiovascular health. Mol Asp Med 2010, 31(6):495-502.
3. McKay D.L., Blumberg J.B. The role of tea in human health: An update. JAm Coll Nutr 2002, 21(1):1-13.
4. Yang T.T., Koo M.W. Hypocholesterolemic effects of Chinese tea. Pharmacol Res 1997, 35(6):505-512.
5. Habauzit V., Morand C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: An update for clinicians. Ther Adv Chronic Dis 2012, 3(2):87-106.
6. Ikeda I., Yamahira T., Kato M., Ishikawa A. Black-tea polyphenols decrease micellar solubility of cholesterol invitro and intestinal absorption of cholesterol in rats. JAgric Food Chem 2010, 58(15):8591-8595.
7. Singh D.K., Banerjee S., Porter T.D. Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells. JNutr Biochem 2009, 20(10):816-822.
8. Leung L.K., Su Y., Chen R., Zhang Z., Huang Y., Chen Z.Y. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 2001, 131(9):2248-2251.
9. Ikeda I., Imasato Y., Sasaki E., et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992, 1127(2):141-146.
10. Vinson J.A., Dabbagh Y.A. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: Mechanisms for the epidemiological benefits of tea drinking. FEBS Lett 1998, 433(1-2):44-46.
11. Matsuda H., Chisaka T., Kubomura Y., et al. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. JEthnopharmacol 1986, 17(3):213-224.
12. Chisaka T., Matsuda H., Kubomura Y., Mochizuki M., Yamahara J., Fujimura H. The effect of crude drugs on experimental hypercholesteremia: Mode of action of (-)-epigallocatechin gallate in tea leaves. Chem Pharm Bull 1988, 36(1):227-233.
13. Suzuki H., Ishigaki A., Hara Y. Long-term effect of a trace amount of tea catechins with perilla oil on the plasma lipids in mice. Int J Vitam Nutr Res 1998, 68(4):272-274.
14. Huang H.-C., Lin J.-K. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food Funct 2012, 3(2):170-177.
15. Miura Y., Chiba T., Tomita I., et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. JNutr 2001, 131(1):27-32.
16. Xu R., Yokoyama W.H., Irving D., Rein D., Walzem R.L., German J.B. Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 1998, 137(1):29-36.
17. Matsumoto N., Okushio K., Hara Y. Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. JNutr Sci Vitaminol 1998, 44(2):337-342.
18. Yokozawa T., Dong E., Nakagawa T., Kim D.W., Hattori M., Nakagawa H. Effects of Japanese black tea on atherosclerotic disorders. Biosci Biotechnol Biochem 1998, 62(1):44-48.
19. Alshatwi A.A., Al Obaaid M.A., Al Sedairy S.A., Ramesh E., Lei K.Y. Black and green tea improves lipid profile and lipid peroxidation parameters in Wistar rats fed a high-cholesterol diet. JPhysiol Biochem 2011, 67(1):95-104.
20. Vermeer M.A., Mulder T.P.J., Molhuizen H.O.F. Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles. JAgric Food Chem 2008, 56(24):12031-12036.
21. Fujita H., Yamagami T. Extract of black tea (pu-ehr) inhibits postprandial rise in serum cholesterol in mice, and with long term use reduces serum cholesterol and low density lipoprotein levels and renal fat weight in rats. Phytother Res 2008, 22(10):1275-1281.
22. Hakim I.A., Alsaif M.A., Alduwaihy M., Al-Rubeaan K., Al-Nuaim A.R., Al-Attas O.S. Tea consumption and the prevalence of coronary heart disease in Saudi adults: Results from a Saudi national study. Prev Med 2003, 36(1):64-70.
23. Stensvold I., Tverdal A., Solvoll K., Foss O.P. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 1992, 21(4):546-553.
24. Solvoll K., Selmer R., Løken E.B., Foss O.P., Trygg K. Coffee, dietary habits, and serum cholesterol among men and women 35-49 years of age. Am J Epidemiol 1989, 129(6):1277-1288.
25. Tuomilehto J., Tanskanen A., Pietinen P., et al. Coffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women. JEpidemiol Community Health 1987, 41(3):237-242.
26. Green M., Jucha E. Association of serum lipids with coffee, tea, and egg consumption in free-living subjects. JEpidemiol Community Health 1986, 40(4):324-329.
27. Little J.A., Shanoff H.M., Csima A., Toronto M.A., Yano R. Coffee and serum-lipids in coronary heart-disease. Lancet 1966, 1(7440):732-734.
28. Klatsky A.L., Petitti D.B., Armstrong M.A., Friedman G.D. Coffee, tea and cholesterol. Am J Cardiol 1985, 55(5):577-578.
29. Carson C.A., Cauley J.A., Caggiula A.W. Relation of caffeine intake to blood lipids in elderly women. Am J Epidemiol 1993, 138(2):94-100.
30. Nichols A.B., Ravenscroft C., Lamphiear D.E., Ostrander L.D. Independence of serum lipid levels and dietary habits. The Tecumseh study. JAMA 1976, 236(17):1948-1953.
31. Green M.S., Harari G. Association of serum lipoproteins and health-related habits with coffee and tea consumption in free-living subjects examined in the Israeli CORDIS Study. Prev Med 1992, 21(4):532-545.
32. Kark J.D., Friedlander Y., Kaufmann N.A., Stein Y. Coffee, tea, and plasma cholesterol: The Jerusalem Lipid Research Clinic prevalence study. Br Med J (Clin Res Ed) 1985, 291(6497):699-704.
33. Bahorun T., Luximon-Ramma A., Neergheen-Bhujun V.S., et al. The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev Med 2012, 54(suppl):S98-S102.
34. Kubota K., Sumi S., Tojo H., et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract. Nutr Res 2011, 31(6):421-428.
35. Mukamal K.J., MacDermott K., Vinson J.A., Oyama N., Manning W.J., Mittleman M.A. A6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 2007, 154(4):724.e1-724.e6.
36. Davies M.J., Judd J.T., Baer D.J., et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. JNutr 2003, 133(10):3298S-3302S.
37. Bingham S.A., Vorster H., Jerling J.C., et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 1997, 78(1):41-55.
38. Trautwein E.A., Du Y., Meynen E., et al. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Eur J Nutr 2010, 49(1):27-35.
39. Fujita H., Yamagami T. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia. Nutr Res 2008, 28(7):450-456.
40. Hartley L., Flowers N., Holmes J., et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013, 6(6):CD009934.
41. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993, 269(23):3015-3023.
42. Hodson L., Skeaff C.M., McKenzie J.E. Maximal response to a plasma cholesterol-lowering diet is achieved within two weeks. Nutr Metab Cardiovasc Dis 2002, 12(5):291-295.
43. Tijburg L.B., Wiseman S.A., Meijer G.W., Weststrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 1997, 135(1):37-47.
44. Higdon J.V., Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43(1):89-143.
45. Riemersma R.A., Rice-Evans C.A., Tyrrell R.M., Clifford M.N., Lean M.E. Tea flavonoids and cardiovascular health. QJM 2001, 94(5):277-282.
46. Hollman P.C., Tijburg L.B., Yang C.S. Bioavailability of flavonoids from tea. Crit Rev Food Sci Nutr 1997, 37(8):719-738.
47. Yang C.S., Lee M.J., Chen L. Human salivary tea catechin levels and catechin esterase activities: Implication in human cancer prevention studies. Cancer Epidemiol Biomarkers Prev 1999, 8(1):83-89.
48. Ishikawa T., Suzukawa M., Ito T., et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997, 66(2):261-266.
49. Hollman P.C.H. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol. 2004, 42(s1):74-83.
50. Van het Hof K.H., de Boer H.S., Wiseman S.A., Lien N., Westrate J.A., Tijburg L.B. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997, 66(5):1125-1132.
51. Ervin R.B., Wright J.D., Wang C.-Y., Kennedy-Stephenson J. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Adv Data 2004, (348):1-6.
52. Grand Forks Analysis of Nutrient Data 2011, US Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, US Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND.
53. Winham D.M., Hutchins A.M. Perceptions of flatulence from bean consumption among adults in 3 feeding studies. Nutr J 2011, 10:128.
54. Roza A.M., Shizgal H.M. The Harris Benedict equation reevaluated: Resting energy requirements and the body cell mass. Am J Clin Nutr 1984, 40(1):168-182.
55. Harris J.A., Benedict F.G. ABiometric Study of Basal Metabolism in Man 1919, Carnegie Institution of Washington, Washington, DC.
56. Energy and Protein Requirements (Report of Joint FAO/WHO/UNE Expert Consultation) 1985, 205. World Health Organization, World Health Organization, Geneva.
57. Warnick G.R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 1986, 129:101-123.
58. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982, 28(6):1379-1388.
59. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.